Diener HC, McAllister P, Jurgens TP, Kessler Y, et al. Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies. Cephalalgia 2022 Mar 25:3331024221076485. doi: 10.1177/03331024221076485.
PMID: 35331009